Atlas Trials

Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and Efficacy

Clinical trial NCT00001677 · COMPLETED

Trial details

NCT number
NCT00001677
Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Arthritis, RheumatoidSynovitis
Start date
1998-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.